Phio Pharmaceuticals Corp.
PHIO
$2.36
-$0.04-1.67%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 27.86% | 33.96% | 36.38% | 30.37% | 24.61% |
| Total Depreciation and Amortization | -99.42% | -80.98% | -58.29% | -32.80% | -9.04% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -57.79% | -67.13% | -29.46% | -21.71% | 4.13% |
| Change in Net Operating Assets | 119.95% | 74.25% | -1,930.91% | -468.87% | -319.82% |
| Cash from Operations | 36.57% | 33.84% | 26.82% | 22.65% | 11.58% |
| Capital Expenditure | 40.00% | 80.00% | 100.00% | 100.00% | 70.59% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 220.00% | 260.00% | 100.00% | 100.00% | 70.59% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 76.80% | -46.30% | 0.04% | -52.38% | -- |
| Repurchase of Common Stock | 60.00% | 83.78% | 83.33% | 87.18% | 87.18% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | 100.00% | 100.00% | 100.00% |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 76.89% | -46.09% | 0.64% | -52.11% | 19,194.87% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 360.65% | 6.97% | 49.53% | 0.80% | 77.15% |